Common use of Research Use Reporting Clause in Contracts

Research Use Reporting. To assure adherence to NIH policies and procedures for genomic data, PIs agree to provide annual progress updates as part of the annual project renewal or project close-out processes, prior to the expiration of the 1-year data access period. PIs who are seeking renewal or close-out of a project agree to complete the appropriate online forms and provide specific information such as how the data have been used, including publications or presentations that resulted from the use of the requested dataset(s), a summary of any plans for future research use (if the requester is seeking renewal), any violations of the terms of access described within this Data Use Certification Agreement and the implemented remediation, and information on any downstream intellectual property generated from the data. PIs also may include general comments regarding topics such as the effectiveness of the data access process (e.g., ease of access and use), appropriateness of data format, challenges in following the policies, and suggestions for improving data access or the program in general. Information provided in the progress updates helps NIH evaluate program activities and may be considered by the NIH GDS governance committees as part of NIH’s effort to provide ongoing oversight and management of data sharing activities subject to the GDS Policy. Note that any inadvertent or inappropriate data release incidents should be reported to the eNCI DAC according to the agreements and instructions under Term 6.

Research Use Reporting. To assure adherence to NIH policies and procedures for genomic data, PIs agree to provide annual progress updates as part of the annual project renewal or project close-out processes, prior to the expiration of the 1-year data access period. PIs who are seeking renewal or close-out of a project agree to complete the appropriate online forms and provide specific information such as how the data have been used, including publications or presentations that resulted from the use of the requested dataset(s), a summary of any plans for future research use (if the requester is seeking renewal), any violations of the terms of access described within this Data Use Certification Agreement and the implemented remediation, and information on any downstream intellectual property generated from the data. PIs also may include general comments regarding topics such as the effectiveness of the data access process (e.g., ease of access and use), appropriateness of data format, challenges in following the policies, and suggestions for improving data access or the program in general. Information provided in the progress updates helps NIH evaluate program activities and may be considered by the NIH GDS governance committees as part of NIH’s effort to provide ongoing oversight and management of data sharing activities subject to the GDS Policy. Note that any inadvertent or inappropriate data release incidents should be reported to the eNCI DAC NIAGADS Data Use Committee according to the agreements and instructions under Term 6.

Research Use Reporting. To assure adherence to NIH and WIHS policies and procedures for genomic data, PIs agree to provide annual progress updates on how these data have been used, including presentations, publications, and the generation of intellectual property. This information helps WIHS evaluate program activities and may be considered by the WIHS governance committees as part of NIH’s effort to provide ongoing oversight and management of WIHS genomic data sharing activities. As stipulated in the WIHS Data Use Agreement, progress updates must be provided as part of the annual project renewal or project close-out processes, prior to the expiration of the 1-year data access period. PIs who are seeking renewal or close-out of a project agree to complete the appropriate online forms and provide specific information such as how the data have been used, including publications or presentations that resulted from the use of the requested dataset(s), a summary of any plans for future research use (if the requester is seeking renewal)use, any violations of the terms of access described within this Data Use Certification Agreement DUA and the implemented remediation, and information on any downstream intellectual property generated from the data. PIs also may include general comments regarding topics such as the effectiveness of the data access process (e.g., ease of access and use), appropriateness of data format, challenges in following the policies, and suggestions for improving data access or the program in general. Information provided in the progress updates helps NIH evaluate program activities and may be considered by the NIH GDS governance committees as part of NIH’s effort to provide ongoing oversight and management of data sharing activities subject to the GDS Policy. Note that any inadvertent or inappropriate data release incidents should be reported to the eNCI DAC WDMAC (xxxxx.xxxxx@xxx.xxx) according to the agreements and instructions under Term 65.

Research Use Reporting. To assure adherence to NIH policies and procedures for genomic data, PIs agree to provide annual progress updates as part of the annual project renewal or project close-out processes, prior to the expiration of the 1-year data access period. PIs who are seeking renewal or close-out of a project agree to complete the appropriate online forms and provide specific information such as how the data have been used, including publications or presentations that resulted from the use of the requested dataset(s), a summary of any plans for future research use (if the requester is seeking renewal), any violations of the terms of access described within this Data Use Certification Agreement and the implemented remediation, and information on any downstream intellectual property generated from the data. PIs also may include general comments regarding topics such as the effectiveness of the data access process (e.g., ease of access and use), appropriateness of data format, challenges in following the policies, and suggestions for improving data access or the program in general. Information provided in the progress updates helps NIH evaluate program activities and may be considered by the NIH GDS governance committees as part of NIH’s effort to provide ongoing oversight and management of data sharing activities subject to the GDS Policy. Note that any inadvertent or inappropriate data release incidents should be reported to the eNCI [NIAAA] DAC according to the agreements and instructions under Term 6.